Registration

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for AUXILIUM PHARMACEUTICALS

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA regulation of compounding pharmacies, health insurance coding issues

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON New Policy Advisor, Speaker D. Hastert Chief Health (contd.) ; ; Counsel, House Energy/Com Chief Health Counsel (contd.) ; ; House Ways/Means Health Policy Dir., Senate HELP Cmte.
MICHAEL N DRUCKMAN New —
KATHLEEN M MCAULIFFE New —

Health Issues HCR

FDA regulation of compounding pharmacies, health insurance coding issues

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON New Policy Advisor, Speaker D. Hastert Chief Health (contd.) ; ; Counsel, House Energy/Com Chief Health Counsel (contd.) ; ; House Ways/Means Health Policy Dir., Senate HELP Cmte.
MICHAEL N DRUCKMAN New —
KATHLEEN M MCAULIFFE New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.